Upsher Smith presented positive Phase 1 data for its USL261 intranasal midazolam at the American Academy of Neurology (AAN) Meeting this week. The company launched a website to recruit patients for a Phase 3 study of the product last year. The intranasal formulation is being developed for the rescue treatment of seizures in epilepsy patients and is "intended to … [Read more...] about Upsher Smith presents positive Phase 1 data for intranasal midazolam
Medical
The Lancet launches new respiratory medicine journal
The first issue of the Lancet Respiratory Medicine journal is now available online and in print. Volume 1, Issue 1 includes articles on the efficacy of ICS/LABA combination inhalers and on the appropriateness of GOLD COPD categories among others. The issue includes a section called "Country in Focus," plus spotlights, comment, news, and 2012 research highlights … [Read more...] about The Lancet launches new respiratory medicine journal
Study shows that use of Asthmapolis system improves asthma control
A study published February 27, 2013 in PLOS ONE found that patients using the Asthmapolis remote inhaler monitoring system who received weekly email reports on their inhaler usage experienced significant reduction in symptoms and reported improved control. At the end of the study 75% of participants had achieved control of their asthma as measured by the the Asthma … [Read more...] about Study shows that use of Asthmapolis system improves asthma control
Savara announces clinical advisory board
According to Savara Pharmaceuticals, the company has created a Clinical Advisory Board to provide advice on the development of AeroVanc vancomycin hydrochloride inhalation powder for the treatment of MRSA lung infections in patients with cystic fibrosis. The five members of the new board are: Michael P. Boyle, Associate Professor of Medicine and Director of the … [Read more...] about Savara announces clinical advisory board
Critical reports positive results for intranasal growth hormone study
According to Critical Pharmaceuticals, a Phase 1b study has shown that its CP024 dry powder intranasal human growth hormone (hGH) was well tolerated with only a few minor adverse effects and showed a linear dose response. CP024 also induced production of therapeutic levels of insulin-like growth factor (IGF-1), making it the first nasal formulation of growth hormone … [Read more...] about Critical reports positive results for intranasal growth hormone study
NEONC announces planned trial of intranasal therapy for brain cancer
California-based NEONC Technologies has announced plans for clinical trials of its NEO100 intranasal formulation of monoterpene perillyl alcohol (POH) for the treatment of gliomas and other CNS cancers. NEONC Chairman and CEO Thomas Chen, who is also Co-Director of the USC/Norris Neuro-Oncology Program and Professor of Neurological Surgery and Pathology at USC's Keck … [Read more...] about NEONC announces planned trial of intranasal therapy for brain cancer
NICE recommends TOBI Podhaler and Colobreathe for CF patients
The UK's National Institute for Health and Clinical Excellence (NICE) has issued a qualified recommendation for Forest Lab's Colobreath colistimethate sodium and Novartis's TOBI Podhaler tobramycin dry powders for inhalation as options for the treatment of P. aeruginosa lung infections in patients with cystic fibrosis. The recommendation is a final draft; the final … [Read more...] about NICE recommends TOBI Podhaler and Colobreathe for CF patients
Fast food consumption linked to severity of asthma, rhinitis in children
An article posted online in Thorax on January 14, 2013 finds that children and teens who eat three or more servings of fast food per week have a significantly increased risk of severe asthma. The same fast food intake was also associated with increased risk of eczema and rhinitis, while fruit consumption was found to have an inverse association with severe asthma and … [Read more...] about Fast food consumption linked to severity of asthma, rhinitis in children
Teva Pro-Air MDI with dose counter now available in US
Teva Respiratory says that the ProAir HFA metered dose inhaler with dose counter for the treatment of asthma is now available. The albuterol MDI with dose counter was approved by the FDA in March 2012. At the time, the company announced that the new inhaler would be available by the end of 2012. Teva says that it needed time to manufacture a sufficient inventory to … [Read more...] about Teva Pro-Air MDI with dose counter now available in US
Matrixx Initiatives recalls single lot of Zicam nasal spray
Matrixx Initiatives has voluntarily recalled a single lot of Zicam Extreme Congestion Relief nasal gel spray due to contamination with Burkholderia cepacia in a single sample. Zicam is a homeopathic product available over the counter in the US. The affected lot, which was distributed to retailers throughout the US, is number 2J23. The 0.5 oz spray bottles are … [Read more...] about Matrixx Initiatives recalls single lot of Zicam nasal spray